English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
愛康醫療三度榮膺北京市科技一等獎 推動髖關節發育不良診療技術革新
Nov 20, 2024 19:35 HKT
爱康医疗三度荣膺北京市科技一等奖 推动髋关节发育不良诊疗技术革新
Nov 20, 2024 19:12 HKT
JBM Healthcare Announces FY2025 Interim Results
Nov 19, 2024 20:51 HKT
健倍苗苗公佈二零二五財年中期業績 純利飆升53.4%至95.9百萬港元
Nov 19, 2024 20:39 HKT
健倍苗苗公布二零二五财年中期业绩 纯利飙升53.4%至95.9百万港元
Nov 19, 2024 20:23 HKT
Everest Medicines Announces NEFECON(R)'s Full Approval in South Korea
Nov 19, 2024 17:37 HKT
雲頂新耀宣佈耐賦康(R)在韓國獲批 商業化進程再創里程碑
Nov 19, 2024 17:28 HKT
云顶新耀宣布耐赋康(R)在韩国获批 商业化进程再创里程碑
Nov 19, 2024 17:10 HKT
Beat The Silent Disease of Osteoporosis with LAC, Before It's Too Late!
Nov 18, 2024 13:00 HKT
雲頂新耀宣佈耐賦康(R)Ⅲ期試驗開放標籤第二療程擴展研究積極結果
Nov 11, 2024 12:23 HKT
云顶新耀宣布耐赋康(R)Ⅲ期试验开放标签第二疗程扩展研究积极结果
Nov 11, 2024 12:15 HKT
JBM Healthcare Issues Positive Profit Alert
Nov 04, 2024 15:00 HKT
健倍苗苗發佈盈喜 預期股東應佔綜合溢利增加不少於50%
Nov 01, 2024 13:04 HKT
健倍苗苗发布盈喜 预期股东应占综合溢利增加不少于50%
Nov 01, 2024 12:56 HKT
Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio
Oct 29, 2024 20:16 HKT
TOPVISION Transfers From LEAP Market To ACE Market, Signs Underwriting Agreement With Hong Leong Investment Bank
Oct 29, 2024 17:30 HKT
Everest Medicines Announces the Launch of VELSIPITY(R) in the Guangdong-Hong Kong-Macau Greater Bay Area
Oct 25, 2024 11:28 HKT
雲頂新耀宣佈伊曲莫德(VELSIPITY(R))獲批進入粵港澳大灣區 為潰瘍性結腸炎患者帶來新選擇
Oct 25, 2024 11:20 HKT
云顶新耀宣布伊曲莫德(VELSIPITY)获批进入粤港澳大湾区 为溃疡性结肠炎患者带来新选择
Oct 25, 2024 11:20 HKT
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award'
Oct 25, 2024 09:18 HKT
Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: